NANOVIRICIDES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $24.8M | $15.6M |
| Jun 2022 | — | $23.1M | $14.1M |
| Sep 2022 | — | $21.6M | $12.9M |
| Dec 2022 | — | $19.9M | $11.4M |
| Mar 2023 | — | $18.2M | $9.7M |
| Jun 2023 | — | $14.9M | $8.1M |
| Sep 2023 | — | $13.0M | $7.0M |
| Dec 2023 | — | $12.5M | $5.2M |
| Mar 2024 | — | $10.7M | $3.3M |
| Jun 2024 | — | $11.5M | $4.8M |
| Sep 2024 | — | $10.1M | $3.9M |
| Dec 2024 | — | $10.4M | $4.0M |
| Mar 2025 | — | $8.8M | $2.5M |
| Jun 2025 | — | $7.5M | $1.6M |
| Sep 2025 | — | $7.2M | $1.1M |
| Dec 2025 | — | $11.1M | $5.2M |
| Mar 2026 | — | $9.2M | $3.2M |